Circulating ceruloplasmin, ceruloplasmin-associated genes, and the incidence of atrial fibrillation in the atherosclerosis risk in communities study

International Journal of Cardiology

Volumn 241, Issue , 2017, Pages 223-228

  Arenas de Larriva, Antonio P ^a,b,c   Norby, Faye L ^a   Chen, Lin Y ^d   Soliman, Elsayed Z ^e   Hoogeveen, Ron C ^f   Arking, Dan E ^g   Loehr, Laura R ^h   Alonso, Alvaro ⁱ  

^a UNIVERSITY OF MINNESOTA   (United States)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c Instituto de Salud Carlos III   (Spain)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e WAKE FOREST UNIVERSITY   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h University of North Carolina at Chapel Hill   (United States)

ⁱ EMORY UNIVERSITY   (United States)

Author keywords

Atrial fibrillation; Ceruloplasmin; Oxidative stress; Single nucleotide polymorphism

Indexed keywords

CERULOPLASMIN; BIOLOGICAL MARKER;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ATHEROSCLEROSIS; ATRIAL FIBRILLATION; BLOOD SAMPLING; CARDIOVASCULAR RISK; CAUCASIAN; CONTROLLED STUDY; DEATH CERTIFICATE; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RISK ASSESSMENT; BLOOD; GENETIC ASSOCIATION STUDY; GENETICS; INDEPENDENT LIVING; METABOLISM; MIDDLE AGED; PROCEDURES;

AGED; ATHEROSCLEROSIS; ATRIAL FIBRILLATION; BIOMARKERS; CERULOPLASMIN; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; INCIDENCE; INDEPENDENT LIVING; MALE; MIDDLE AGED;

EID: 85017537305     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2017.04.005     Document Type: Article

References (23)

1. Go, A.S., Hylek, E.M., Phillips, K.A., et al. Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA 285 (2001), 2370–2375.
2. Miyasaka, Y., Barnes, M.E., Gersh, B.J., et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114 (2006), 119–125.
3. Jeremy, J.Y., Shukla, N., Ceruloplasmin dysfunction: a key factor in the pathophysiology of atrial fibrillation?. J. Intern. Med., 275(2), 2014, 191-4.
4. Dadu, R.T., Dodge, R., Nambi, V., et al. Ceruloplasmin and heart failure in the atherosclerosis risk in communities study. Circ. Heart Fail., 6(5), 2013, 936-43.
5. Tang, W.H., Wu, Y., Hartiala, J., et al. Clinical and genetic association of serum ceruloplasmin with cardiovascular risk. Arterioscler. Thromb. Vasc. Biol. 32:2 (2012), 516–522.
6. Kennedy, D.J., Fan, Y., Wu, Y., Pepoy, M., Hazen, S.L., Tang, W.H., Plasma ceruloplasmin, a regulator of nitric oxide activity, and incident cardiovascular risk in patients with CKD. Clin. J. Am. Soc. Nephrol. 9:3 (2014), 462–467.
7. Adamsson Eryd, S., Sjogren, M., Smith, J.G., et al. Ceruloplasmin and atrial fibrillation: evidence of causality from a population-based Mendelian randomization study. J. Intern. Med., 275(2), 2014, 164-71.
8. Investigators, A.R.I.C., The atherosclerosis risk in communities (ARIC) study: design and objectives. Am. J. Epidemiol. 129 (1989), 687–702.
9. Alonso, A., Agarwal, S.K., Soliman, E.Z., et al. Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis risk in communities (ARIC) study. Am. Heart J. 158 (2009), 111–117.
10. Soliman, E.Z., Prineas, R.J., Case, D., et al. Ethnic distribution of electrocardiographic predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the atherosclerosis risk in communities study (ARIC). Stroke 40 (2009), 1204–1211.
11. Fuchs, F.D., Chambless, L.E., Whelton, P.K., et al. Alcohol consumption and the incidence of hypertension: the atherosclerosis risk in communities study. Hypertension, 37(5), 2001, 1242-50.
12. Kwon, Y., Norby, F.L., Jensen, P.N., et al. Association of smoking, alcohol, and obesity with cardiovascular death and ischemic stroke in atrial fibrillation: the atherosclerosis risk in communities (ARIC) study and cardiovascular health study (CHS). PLoS One, 11(1), 2016, e0147065.
13. Eriksson, H., Caidahl, K., Larsson, B., et al. Cardiac and pulmonary causes of dyspnoea—validation of a scoring test for clinical-epidemiological use: the study of men born in 1913. Eur. Heart J., 8(9), 1987, 1007-14.
14. Loehr, L.R., Rosamond, W.D., Chang, P.P., et al. Heart failure incidence and survival (from the atherosclerosis risk in communities study). Am. J. Cardiol. 101 (2008), 1016–1022.
15. White, A.D., Folsom, A.R., Chambless, L.E., et al. Community surveillance of coronary heart disease in the atherosclerosis risk in communities (ARIC) study: methods and initial two years’ experience. J. Clin. Epidemiol. 49 (1996), 223–233.
16. Ostbye, T., Levy, A., Mayo, N., et al. Hospitalization and case-fatality rates for subarachnoid hemorrhage in Canada from 1982 through 1991: the Canadian Collaborative Study Group of Stroke Hospitalizations. Stroke 28 (1997), 793–798.
17. Rosamond, W., Folsom, A.R., Chambless, L.E., et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the atherosclerosis risk in communities (ARIC) cohort. Stroke 30 (1999), 736–743.
18. Alonso, A., Misialek, J.R., Amiin, M.A., et al. Circulating levels of liver enzymes and incidence of atrial fibrillation: the atherosclerosis risk in communities cohort. Heart 100 (2014), 1511–1516.
19. Sovari, Ali A., Cellular and molecular mechanisms of arrhythmia by oxidative stress. Cardiol. Res. Pract., 2016, 2016, 7, 9656078.
20. Massion, P.B., Feron, O., Dessy, C., et al. Nitric oxide and cardiac function: ten years after, and continuing. Circ. Res. 93 (2003), 388–398.
21. Michel, T., NO way to relax: the complexities of coupling nitric oxide synthase pathways in the heart. Circulation 121 (2010), 484–486.
22. Schillinger, K.J., Patel, V.V., Atrial fibrillation in the elderly: the potential contribution of reactive oxygen species. J. Geriatr. Cardiol. 9 (2012), 379–388.
23. Jeong, E.M., Liu, M., Sturdy, M., et al. Metabolic stress, reactive oxygen species, and arrhythmia. J. Mol. Cell. Cardiol., 52, 2012, 454-63.